Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polymorphisms in the Renin-Angiotensin System and eNOS Glu298Asp Genes Are Associated with Increased Risk for Essential Hypertension in a Mexican Population. | J Renin Angiotensin Aldosterone Syst | 2023 | 36845669 | PubTator, text mining | PubMed |
| Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications. | Front Pharmacol | 2023 | 36843948 | PubTator, text mining | PubMed |
| The Mitochondrion: A Promising Target for Kidney Disease. | Pharmaceutics | 2023 | 36839892 | PubTator, text mining | PubMed |
| Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson's Disease. | Life (Basel) | 2023 | 36836893 | PubTator, text mining | PubMed |
| Diagnosis and Management of Neuropathic Pain in Spine Diseases. | J Clin Med | 2023 | 36835916 | PubTator, text mining | PubMed |
| The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging-A Prospective Longitudinal Cohort Study. | Int J Mol Sci | 2023 | 36835445 | PubTator, text mining | PubMed |
| Genetics, Treatment, and New Technologies of Hormone Receptor-Positive Breast Cancer. | Cancers (Basel) | 2023 | 36831644 | PubTator, text mining | PubMed |
| Interactions of the eNOS and ACE genes and cigarette smoking in chronic obstructive pulmonary disease. | J Med Biochem | 2023 | 36819141 | PubTator, text mining | PubMed |
| Ultra-low-coverage genome-wide association study-insights into gestational age using 17,844 embryo samples with preimplantation genetic testing. | Genome Med | 2023 | 36788602 | PubTator, text mining | PubMed |
| In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates. | Arab J Chem | 2023 | 36777994 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients. | J Med Virol | 2023 | 36756942 | PubTator, text mining | PubMed |
| Mini-review: Angiotensin- converting enzyme 1 (ACE1) and the impact for diseases such as Alzheimer's disease, sarcopenia, cancer, and COVID-19. | Front Aging | 2023 | 36756193 | PubTator, text mining | PubMed |
| Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. | Pharmacol Rev | 2023 | 36753049 | PubTator, text mining | PubMed |
| Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure. | ESC Heart Fail | 2023 | 36717981 | PubTator, text mining | PubMed |
| mRNA Metabolism and Hypertension. | Biomedicines | 2023 | 36672629 | PubTator, text mining | PubMed |
| Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2. | J Cardiovasc Dev Dis | 2023 | 36661909 | PubTator, text mining | PubMed |
| Thermodynamic architecture and conformational plasticity of GPCRs. | Nat Commun | 2023 | 36624096 | PubTator, text mining | PubMed |
| Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity. | Cancers (Basel) | 2023 | 36612307 | PubTator, text mining | PubMed |
| Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries. | JAMA Netw Open | 2023 | 36598787 | PubTator, text mining | PubMed |
| LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice. | Peptides | 2023 | 36493954 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=11